OASM
Oasmia Pharmaceutical AB
OASM
OASM
Delisted
OASM was delisted on the 21st of August, 2019.
4 hedge funds and large institutions have $49K invested in Oasmia Pharmaceutical AB in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$24K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$3K |
Top Sellers
| 1 |
SCM
1
Sio Capital Management
New York
|
$0 |
| 2 |
SM
2
Sabby Management
Miami Beach,
Florida
|
$0 |
| 3 |
3
Bank of New York Mellon
New York
|
$0 |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$22K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $24K | 18,439 | +18,439 | New |
|
|
2
Citadel Advisors
Miami,
Florida
| $22K | 16,734 | -1,754 | -9% |
|
|
3
UBS Group
Zurich,
Switzerland
| $3K | 2,573 | +534 | +26% |
|
|
SCM
4
Sio Capital Management
New York
| – | – | -203,170 | Closed |
|
|
SM
5
Sabby Management
Miami Beach,
Florida
| – | – | -19,000 | Closed |
|
|
6
Bank of New York Mellon
New York
| – | – | -13,450 | Closed |
|
7
Morgan Stanley
New York
| $0 | 1 | – | – |
|